Now, a new vaccine designed to train the body’s immune system to attack this rogue protein is showing promise in early trials ...

T-bet is a transcription factor, one of the control proteins in the cell nucleus that can turn specific groups of genes on ...

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect millions of people ...

Findings from a Phase I trial initiated by Dana-Farber Cancer Institute have showed NeoVaxMI's improved immune response in melanoma patients.

These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

Although deaths from cancer have gone down over the last couple decades, the disease remains one of the leading causes of death in the United States, just as it has for the last 75 years, according to ...

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

Mitochondria are cell organelles surrounded by a double membrane. In addition to numerous essential functions in the ...

Patients using steroids, especially at high-doses, before taking immune checkpoint inhibitors for non–small cell lung cancer ...

Researchers have developed a new gene-editing platform that will enable safer and more effective T cell–based immunotherapies ...

Knowable Magazine reports that worm-inspired treatments show promise for metabolic diseases by reducing inflammation and ...